Trials / Recruiting
RecruitingNCT05923489
Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients
Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients (The REVISE Trial)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,618 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of clinical outcomes between routine angiography follow-up and routine clinical follow-up after percutaneous coronary intervention in high-risk patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Routine Angiography Follow-up | Patients in the RAF group will have routine angiography follow-up at 12 months after revascularization. |
| DIAGNOSTIC_TEST | Routine Clinical Follow-up | Patients in the RCF group will have routine clinical follow-up at 12 months after revascularization, and the physician will decide whether further invasive testing is needed. |
Timeline
- Start date
- 2023-10-26
- Primary completion
- 2026-10-15
- Completion
- 2029-10-15
- First posted
- 2023-06-28
- Last updated
- 2023-12-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05923489. Inclusion in this directory is not an endorsement.